ADARx Pharmaceuticals, Inc. (ADRX)

Last Closing Price: 14.00 (2026-11-16)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

ADARx Pharmaceuticals, Inc. (ADRX) had Earnings per Share (EPS) (Diluted) of $-1.74 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$2.22M
$-28.12M
--
$2.22M
$34.39M
$-32.18M
$4.06M
$-28.12M
$-28.12M
$-28.12M
$-28.12M
$-28.12M
$-28.12M
$-32.18M
$-32.18M
16.13M
16.13M
$-1.74
Earnings per Share (EPS) (Diluted)
$-1.74
Balance Sheet Financials
$918.51M
$4.40M
$10.55M
$929.06M
$43.57M
--
$311.09M
$354.66M
$574.40M
$574.40M
$574.40M
107.26M
Cash Flow Statement Financials
$-76.75M
$78.61M
$502.10M
$66.52M
$570.61M
$504.09M
$4.27M
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--